Landmark £42m trial aiming to revolutionise prostate cancer diagnosis
The £42m TRANSFORM trial will test innovative approaches and compare them to current NHS practice. Previous research has shown that current blood tests – prostate-specific antigen – can help prevent 8% and 20% of prostate cancer deaths, although this …